Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-03-31

Clinical Trial Update: Liposomal Bupivacaine Versus Lidocaine for Skin Graft Donor Site Pain [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing liposomal bupivacaine to lidocaine for donor-site pain after skin grafts in burn patients; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Exparel (liposomal bupivacaine)
  • Lidocaine (Lidocaine)

Snippet

Sponsor: University of Kansas Medical Center | Conditions: Pain, Postoperative, Burns | Phase 4 | Status: COMPLETED | Results posted: 2026-03-31